Skip to content

Efficacy trial of repeated intake of plant derived ingredient. [trial number g2018007]

Efficacy trial of repeated intake of plant derived ingredient. [trial number g2018007] - Efficacy of plant derived ingredient. [trial number g2018007]

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000034130
Enrollment
14
Registered
2018-09-25
Start date
2018-09-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Sponsors

TES Holdings Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) Healthy male adults aged from 20 y to 64 y (2) Subjects with fasting glucose from 100 to 125 mg/dl (3) Subjects can consume test foods, and record life diaries and meal diaries (4) Subjects who have given written informed consent prior to study

Exclusion criteria

Exclusion criteria: (1) Subjects diagnosed with diabetes, or taking drugs related diabetes (2) Subjects who have history or symptom of cardiovascular disease or cerebrovascular disease (3) Subjects who have symptom of liver, kidney or respiratory disease, endocrine disorder, metabolic disorder, organ disorder, gout, rheumatism, autoimmune disease, allergy disease, mental disorder, cancer, infection disease, or other diseases (4) Subjects who have a history of resection of gastrointestinal tract, excluding cecal resection surgery (5) Heavy drinker (over 30g alcohol per day) (6) Subjects who have donated over 200 ml of blood within the last one month prior to the current study or over 400 ml of blood within the last three months prior to the study (7) Subjects who have severe anemia (Hb <=7g/dL) (8) Subjects who have food allergies for test foods (9) Subjects who are planned to participate in other clinical study during current study (10) Subjects who are judged to be inappropriate for the study by the medical doctor or principal investigator for other reason

Design outcomes

Primary

MeasureTime frame
Blood glucose

Secondary

MeasureTime frame
Insulin, glucagon, 1.5-AG, glycol-albumin, gastrointestinal hormone, triglyceride, apo B48, ketone body, body weight, body fat ratio, appetite (questionnaire)

Countries

Japan

Contacts

Public ContactRyoma Shimizu

TES Holdings Co., Ltd. Administrative Department of Clinical Trials

r.shimizu@tes-h.co.jp+81-3-6801-8480

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026